Technical Report: Implementation of GPHF-Minilab Pilot in Afghanistan
One of the biggest challenges developing countries face in their fight against counterfeit and substandard medicines is building their technical capacity to regulate medicines. Without effective and affordable analytical technologies, the quality of the medicines cannot be secured in the country. Global Pharma Health Fund Minilab (GPHF-Minilab) kit is one widely deployed field adapted technology used in many developing countries. Despite the potential of the GPHF-Minilab kit, it has not been formally adopted as a first-line screening technique in the Islamic Republic of Afghanistan. This study aimed to explore the potential applicability by implementing a pilot product screening using GPHF-Minilab kit for samples collected from selected public and private facilities in Afghanistan.